We are investigating the roles of specific biomarkers of progression in the elder male thyroid cancer population.
This project is being funded by the Tulane Center of Excellence in Sex-Based Biology and Medicine (TCESBM) until January 2024.
Sex-specific markers of thyroid cancer
Spatiotemporal transcriptomatic landscape driving thyroid tumurogenesis
In this project, we study the validation of molecular panel and nomogram predicting lymph node metastasis.
This project is being funded by the Tulane School of Medicine Fall Pilot Funding Award until December 2023.
miR-145/MMP9 ratio for predicting recurrence of thyroid cancer
We hope to develop reliable multiplexed assays using nanoparticle-based technology from liquid biopsy samples.
This project is being funded by the American Thyroid Cancer Association, Bite Me Cancer, and ThyCa: Thyroid Cancer Survivors’ Association.
miRNA signature predicting thyroid aggressiveness
We plan to develop prognostic nomogram using miRNA panels during active surveillance of thyroid cancer.
This project was funded by the Tulane School of Medicine Bridge Fund.